Abstract
Test systems to screen for estrogenicity and appropriate biomarkers of human exposure are required for epidemiological studies of endocrine disruption. We addressed these issues by developing and standardising a method to assess the total estrogenic xenobiotic burden in human adipose tissue. In this study, which is the continuation of a previous work, we have improved the protocol for extensive fractionation of a higher number of tissue samples in order to investigate bioaccumulated xenoestrogens that are candidates for estrogenicity and to assess their combined estrogenic effect. This was achieved by extensive HPLC separation of xenoestrogens from endogenous hormones followed by testing of individual fractions in the E-Screen test for estrogenicity. Organochlorine pesticides, PCBs and halogenated bisphenols and alkylphenols were collected in the most lipophilic fractions, followed by progestins, androgens and estradiol esters, and then by steroidal estrogens; phyto- and myco-estrogens were collected around the end of the run. These results were confirmed by exhaustive chemical analysis. In 458 human adipose tissue samples, the total effective xenoestrogen burden was positive in 75% of samples in the pooled fraction that contained organohalogenated xenoestrogens (mean 515.3 pM Eeq/g lipid; range 0–14.5 nM) and in 82% of samples in the pooled fraction where natural estrogens eluted (mean 696.6 pM Eeq/g lipid; range 0–12.9 nM). Organochlorine pesticides emerged as candidate chemicals for the estrogenicity of the first pooled fraction, because DDT and derivatives were present in 98.3% of the samples. However, no correlation was found between the concentration of any single chemical and the estrogenicity determined in the bioassay. There may be several reasons for this lack of concordance: (i) the estrogenic effects depicted in the E-Screen bioassay are a consequence of the combined effect of several organohalogens or (ii) the proliferative effect is due to other chemicals not measured. Because additive, synergistic or antagonistic mechanisms may account for the final effect observed in the pooled fractions, the approach proposed in this work is more appropriate for exposure assessment in epidemiological studies than the determination of individual chemicals in human samples.
Similar content being viewed by others
References
Birnbaum LS, Fenton SE (2003) Environ Health Perspect 111:389–394
Damstra T, Barlow S, Bergman A, Kavlock R, Van der Kraak G. (2002) (eds) Global assessment of the state-of-the-science of endocrine disruptors. WHO, Geneva
Herbs AL, Ulfelder H, Poskanzer DC (1971) N Engl J Med 284:878–881
Colborn T, vom Saal FS, Soto AM (1993) Environ Health Perspect 101:378–384
Snedeker, SM (2001) Environ Health Perspect 109:35–47
Sonnenschein C, Soto AM (1998) J Steroid Biochem Mol Biol 65:143–150
Rasmussen TH, Nielsen JB (2002) Biomarkers 7:322–336
Sonnenschein C, Soto A, Fernández MF, Olea N, Olea-Serrano MF, Ruiz-Lopez MD (1995) Clin Chem 41:1888–1895
Rivas A, Olea N, Olea-Serrano F (1997) TRAC 16:613–619
Pazos P, Pérez P, Rivas A, Nieto R, Botella B, Crespo J, Olea-Serrano F, Fernandez MF, Exposito J, Olea N, Pedraza V (1998) Adv Exp Med Biol 444:29–40
Rivas A, Fernández MF, Cerrillo I, Ibarluzea J, Olea-Serrano MF, Pedraza V, Olea N (2001) APMIS 109:185–197
Soto A, Chung K, Sonnenschein C (1994) Environ Health Perspect 102:380–383
Villalobos M, Olea N, Brotons J, Olea-Serrano MF, Ruiz de Almodovar JM, Pedraza V (1995) Environ Health Perspect 103:844–850
Soto A, Fernández MF, Luizzi MF, Oles Karasko AS, Sonnenschein C (1997) Environ Health Perspect 105:647–654
Ibarlucea JM, Fernández MF, Santamarina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea J, Expósito J, Lorenzo M, Torné P, Pedraza V, Sasco A, Olea N (2004) Cancer causes control (in press)
Okond’ahoka O, Lavaur E, Lesech J, Lich NP, Le Moan G (1984) Ann Fals Exp Chim 77:531–538
Medina MB, Sherman J (1986) Food Addit Contam 3:263–272.
Martinez Vidal JL, Moreno Frias M, Garrido Frenich A, Olea-Serrano F, Olea N (2002) Anal Bioanal Chem 372:766–75
Moreno Frias M, Garrido Frenich A, Martinez Vidal JL, Mateu Sanchez M, Olea F, Olea N (2001) J Chromatogr B Biomed Sci Appl 760:1–15
Soto A, Lin TM, Justicia H (1992) In: Colborn T, Clement C (eds) Chemically induced alterations in sexual development: the wildlife/human connection. Princeton Scientific, Princeton NJ, pp 295–309
Paris A, Rao D (1989) J Steroid Biochem 33:465–472
Nilsson S, Gustafsson JA (2002) Crit Rev Biochem Mol Biol 37:1–28
Pérez P, Pulgar P, Olea-Serrano F, Villalobos M, Rivas A, Metzler M, Pedraza V, Olea N (1998) Environ Health Perspect 106:167–174
Rivas A, Lacroix M, Olea-Serrano F, Laios I, Leclercq G, Olea N (2002) J Steroid Biochem Mol Biol 82:45–53
Güttes S, Failing K, Neumann K, Kleinstein J, Georgii S, Brunn H (1998) Arch Environ Contam Toxicol 35:140–147
Dello Lacovo R, Celentano E, Strollo A, Lazzeta G, Capasso I, Randazzo G (1999) Adv Exp Med Biol 472:57–66
Aronson KJ, Miller AB, Woolcott ChG, Sterns E, McCready DR, Lickley LA (2000) Cancer Epidemiol Biomarkers Prev 9:55–63
Campoy C, Jiménez M, Olea-Serrano MF, Moreno-Frias M, Cañabate F, Olea N, Bayés R, Molina-Font JA (2001) Early Hum Dev 65:183–190
Olea N, Olea-Serrano F, Lardelli P Rivas A, Olea-Serrano MF (1999) Toxicol Ind Health 15:151–158
Gomez-Catalán J, Planas J, Figueras J, Camps M, Corbella J (1993) Bull Environ Contam Toxicol 51:160–164
Gomez-Catalán J, Lezaun M, Figueras J, Corbella J (1995) Bull Environ Contam Toxicol 54:534–540
Sala M, Sunyer J, Otero R, Santiago Silva M, Camps C, Grimalt J (1999) Occup Environ Med 56:152–158
Porta M, Kogevineas M, Zumeta E, Sunyer J, Ribas-Fito N, Grupo de Trabajo sobre Compuestos Tóxicos persistentes y salud del IMIM (2002) Gac Sanit 16:257–266
Botella B, Crespo J, Rivas A, Cerrillo I, Olea-Serrano F, Olea N (2004) Environ Res (in press)
Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J (1998) Steroids 63:319–321
Siiteri PK (1987) Am J Clin Nutr 45:277–282
Payne J, Scholze M, Kortenkamp A (2001) Environ Health Perspect 109:391–397
Shekhar PVM, Werdell J, Basrur VS (1997) J Natl Cancer Inst 89:1774–1782
Rajapakse N, Silva E, Kortenkamp A (2002) Environ Health Perspect 110:917–921
Acknowledgements
We thank Richard Davies for editorial assistance. This research was supported by grants from the Spanish Ministry of Health (FIS 02/1314, FIS G03/176 and FIS C03/081) and the EU Commission (QLRT4–1999-01422 and QLK4-CT-2002-00603).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández, M.F., Rivas, A., Olea-Serrano, F. et al. Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect. Anal Bioanal Chem 379, 163–170 (2004). https://doi.org/10.1007/s00216-004-2558-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-004-2558-5